Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating activities:
Net earnings	$ 297	$ 121
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization	107	118
Stock-based compensation	40	29
Deferred income taxes	(19)	(60)
Loss on divestiture	112	0
Pension settlement charge	0	171
Other	5	8
Changes in:
Receivables, net	64	15
Inventories, net	(12)	43
Prepaid expenses and other current assets	(39)	(20)
Accounts payable and accrued liabilities	(138)	(163)
Income taxes payable / prepaid	(16)	(89)
Net cash provided by operations	401	173
Investing activities:
Capital expenditures	(92)	(76)
Proceeds from divestiture, net of cash divested	128	0
Other	(1)	20
Net cash provided by (used for) investing activities	35	(56)
Financing activities:
Notes and loans payable, net	184	195
Treasury stock purchased	(257)	0
Cash dividends paid to Clorox stockholders	(302)	(298)
Issuance of common stock for employee stock plans and other	29	(1)
Net cash used for financing activities	(346)	(104)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(3)	(23)
Net increase (decrease) in cash, cash equivalents and restricted cash	87	(10)
Cash, cash equivalents and restricted cash:
Beginning of period	207	368
End of period	$ 294	$ 358